Company profile
Latest filings (excl ownership)
No filings
Latest ownership filings
SC 13G/A
Trevi Therapeutics, Inc.
26 Jan 22
SC 13G
Reneo Pharmaceuticals, Inc.
26 Jan 22
SC 13G
Aura Biosciences, Inc.
26 Jan 22
SC 13D
IO Biotech, Inc.
19 Nov 21
4
IO Biotech, Inc.
12 Nov 21
3
IO Biotech, Inc.
4 Nov 21
SC 13G
IMARA Inc.
3 Feb 21
4
IMARA Inc.
16 Mar 20
3
IMARA Inc.
11 Mar 20
SC 13G/A
Spero Therapeutics, Inc.
31 Jan 20
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
9 Nov 21 | Lundbeckfond Invest A/S | Common Stock | Buy | Acquire P | No | No | 14 | 2,142,857 | 30.00 mm | 6,049,452 |
9 Nov 21 | Lundbeckfond Invest A/S | Common Stock | Conversion | Acquire C | No | No | 0 | 1,892,434 | 0.00 | 3,906,595 |
9 Nov 21 | Lundbeckfond Invest A/S | Common Stock | Conversion | Acquire C | No | No | 0 | 2,014,161 | 0.00 | 2,014,161 |
9 Nov 21 | Lundbeckfond Invest A/S | Series C Preferred Stock Common Stock | Conversion | Dispose C | No | No | 0 | 150,534 | 0.00 | 0 |
9 Nov 21 | Lundbeckfond Invest A/S | Series B Preferred Stock Common Stock | Conversion | Dispose C | No | No | 0 | 219,595 | 0.00 | 0 |